18F-FDG PET/CT is used in the follow-up of patients with head and neck squamous cell
cancer (HNSCC). However, its impact on clinical decision making and patient outcome is not …

Objectives Pre-and post-treatment 18 F-FDG PET/CT may have a prognostic role in human
cancers. 18 F-FDG PET/CT after primary surgery for head and neck cancer might also …

Objective The objective of this study was to investigate the independent prognostic value of
dual-time-point 18 F-fluorodeoxyglucose (18 F-FDG) PET-CT imaging in patients with head …

Methods We retrospectively reviewed 35 patients with head and neck squamous cell cancer
(mean age, 61 years; 28 male patients) who underwent 18 F-FDG PET/CT imaging at 3 …

Posttreatment surveillance for the recurrence of head and neck squamous cell carcinoma
(HNSCC) is a diagnostic challenge. Tissue distortion from radiation and surgery can …

Objectives The aims of this study were to evaluate the ability of [18 F] fluorodeoxyglucose
(18 F-FDG)-PET/computed tomography (CT) to identify tumor recurrence, nodal metastases …

Introduction. To determine the value of a FDG-PET-CT scan in patients with locally
advanced head and neck squamous cell carcinoma (HNSCC) prior to chemoradiotherapy …

Purpose Posttreatment follow-up for the recurrence of head and neck squamous cell
carcinoma (HNSCC) is a diagnostic challenge. Tissue distortion from radiation and surgery …

We evaluated the diagnostic performance of 18F‐FDG PET/CT and MRI for the assessment
of head and neck squamous cell carcinoma (HNSCC) relapse. Since early treatment might …

Background: 18-fluorodeoxyglucose positron emission tomography/computed tomography
(18 F-PET/CT) has been widely applied for the imaging of head and neck squamous cell …